Interventional Imaging

A subspecialty of interventional radiology (IR) uses image-guided, minimally-invasive procedures to diagnose and treat various diseases. Interventional radiologists rely on angiography, mobile C-arm and fluoroscopy imaging systems to perform thrombolysis, embolization, biopsies, vascular and other minimally invasive procedures, which can reduce recovery time, risk and costs. Find more IR content on the Society of Interventional Radiology (SIR) page.

Boston Scientific recalls premixed embolic agent after two deaths
There have been a total of 11 incidents so far, including seven injuries and two deaths. Boston Scientific said the agent can still be used if operators follow specific instructions during lower GI bleed embolization procedures.
How a big CMS update on carotid stenting could impact interventional cardiology
Ken Rosenfield, MD, of Massachusetts General Hospital, and William Gray, MD, of Lankenau Heart Institute, detailed the long-term impact of a key policy shift.
Putting US radiology reimbursement cuts in context and what comes next
Richard Heller, MD, a member of the RSNA Board and associate CMO for Rad Partners, explains the impact of the 2024 Medicare cuts and what is at stake.
FDA announces recall of hemodialysis catheters due to risk of leaks, adverse outcomes
“The use of the defective catheter may cause serious adverse health outcomes, including bleeding or the need for surgical removal and replacement of the affected catheter,” according to an FDA advisory.
Gadolinium can be used as substitute for iodine contrast in some interventional imaging procedures
Gadolinium might be an alternative, stop-gap solution for interventional procedures during the current iodine contrast shortage.

Be prepared: IV contrast media shortage could last up to 8 weeks

All formulations and concentrations of GE Healthcare’s Omnipaque (iohexol) are expected to be in short supply until mid-June due to COVID lockdowns where the contrast is manufactured.

May 6, 2022

Around the web

Cardiovascular Business

The push for an independent cardiology board continues

Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.

AI in Healthcare

Biden Administration itemizes AI accomplishments to date

Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.

Cardiovascular Business

‘Concerning’ data connect industry payments to cardiologists with medical device use

U.S. physicians often receive payments from medical device manufacturers and pharmaceutical companies. New research in JAMA found a connection between receiving such payments and using specific devices—should the industry be concerned?

Interventional Imaging

Boston Scientific recalls premixed embolic agent after two deaths

How a big CMS update on carotid stenting could impact interventional cardiology

Putting US radiology reimbursement cuts in context and what comes next

FDA announces recall of hemodialysis catheters due to risk of leaks, adverse outcomes

Gadolinium can be used as substitute for iodine contrast in some interventional imaging procedures

Around the web